Ensuring the policy relevance of population health research: experiences from the Drug Policy Modelling Program
Alison RitterNational Drug and Alcohol Research Centre, The University of New South Wales
Email: alison.ritter@unsw.edu.au
NSW Public Health Bulletin 22(2) 19-22 https://doi.org/10.1071/NB10062
Published: 19 April 2011
Abstract
Illicit drugs are an important public health concern. A unique approach to tackling this problem is represented in the work of the Drug Policy Modelling Program which aims to improve evidence-informed policy by reducing the gap between research and policy. There are three elements to the Drug Policy Modelling Program: generating new knowledge; translating evidence into information of relevance for decision makers; and studying policy processes. Key aspects include the use of computer modelling as a translational tool and the focus on understanding policy processes such as the role of media and politics, important in contextualising the research-policy nexus. Other features of the Drug Policy Modelling Program approach include engagement of diverse disciplines, and government researcher partnerships.
References
[1] Collins DJ, Lapsley HM. The cost of tobacco, alcohol and illicit drug abuse to Australian society in 2004/05. National Drug Strategy Monograph Series No. 64. Commonwealth of Australia; 2008.[2] Hall W. The contribution of research to Australian policy responses to heroin dependence 1990–2001: a personal retrospection. Addiction 2004; 99 560–9.
| The contribution of research to Australian policy responses to heroin dependence 1990–2001: a personal retrospection.Crossref | GoogleScholarGoogle Scholar | 15078230PubMed |
[3] Fitzgerald J, Sewards T. Evidence-Based Practice in the Australian Drug Policy Community. In: Lin V, Gibson B, editors. Evidence-based health policy: problems and possibilities. Melbourne: Oxford University Press; 2003.
[4] Agar M. How the drug field turned my beard grey. Int J Drug Policy 2002; 13 249–59.
| How the drug field turned my beard grey.Crossref | GoogleScholarGoogle Scholar |
[5] Ritter A, Bammer G, Hamilton M, Mazerolle L. DPMP Team. Effective drug policy: a new approach demonstrated in the Drug Policy Modelling Program. Drug Alcohol Rev 2007; 26 265–71.
| DPMP Team. Effective drug policy: a new approach demonstrated in the Drug Policy Modelling Program.Crossref | GoogleScholarGoogle Scholar | 17454015PubMed |
[6] Lin V, Gibson B, editors. Evidence-based health policy: problems and possibilities. Melbourne: Oxford University Press; 2003.
[7] Edwards M. Social science research and public policy: narrowing the divide. Aust J Public Administration 2005; 64 68–74.
| Social science research and public policy: narrowing the divide.Crossref | GoogleScholarGoogle Scholar |
[8] Balas EA, Boren SA. Managing clinical knowledge for health care improvement. In: Bemmel J, McCray AT, editors. Yearbook of Medical Informatics 2000: Patient-Centered Systems. Stuttgart: Schattauer; 2000. pp. 65–70.
[9] Sanson-Fisher RW, Campbell EM, Htun AT, Bailey LJ, Millar CJ. We are what we do: research outputs of public health. Am J Prev Med 2008; 35 380–5.
| We are what we do: research outputs of public health.Crossref | GoogleScholarGoogle Scholar | 18687567PubMed |
[10] Mazerolle L, Soole D, Rombouts S. Monograph No. 05. Drug law enforcement: The evidence. DPMP Monograph Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.
[11] Mazerolle L, Soole D, Rombouts S. Street-level drug law enforcement: a meta-analytic review. J Exp Criminol 2006; 2 409–35.
| Street-level drug law enforcement: a meta-analytic review.Crossref | GoogleScholarGoogle Scholar |
[12] Mazerolle L, Soole D, Rombouts S. Drug law enforcement: a review of the evaluation literature. Police Q 2007; 10 115–53.
| Drug law enforcement: a review of the evaluation literature.Crossref | GoogleScholarGoogle Scholar |
[13] Drew JM. Police responses to the methamphetamine problem: an analysis of the organizational and regulatory context. Police Q, in press.
[14] Brownson RC, Royer C, Ewing R, McBride TD. Researchers and policymakers: travelers in parallel universes. Am J Prev Med 2006; 30 164–72.
| Researchers and policymakers: travelers in parallel universes.Crossref | GoogleScholarGoogle Scholar | 16459216PubMed |
[15] Crosswaite C, Curtice L. Disseminating research results – the challenge of bridging the gap between health research and health action. Health Promot Int 1994; 9 289–96.
| Disseminating research results – the challenge of bridging the gap between health research and health action.Crossref | GoogleScholarGoogle Scholar |
[16] Hanney SR, Gonzalez-Block MA, Buxton MJ, Kogan M. The utilisation of health research in policy-making: concepts, examples and methods of assessment. Health Res Policy Syst 2003; 1 2
| The utilisation of health research in policy-making: concepts, examples and methods of assessment.Crossref | GoogleScholarGoogle Scholar | 12646071PubMed |
[17] Stone D, Maxwell S, Keating M. Bridging research and policy. UK Department for International Development, Radcliffe House, Warwick University: Warwick, UK; 2001. p. 50.
[18] Weiss CH, editor. Using social research in public policy making. Lexington, MA: Lexington Books; 1977.
[19] Meadows DH, Robinson JM. The electronic oracle: computer models and social decisions. Syst Dyn Rev 2002; 18 271–308.
| The electronic oracle: computer models and social decisions.Crossref | GoogleScholarGoogle Scholar |
[20] Zeiler I, Langlands T, Murray JM, Ritter A. Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs. Drug Alcohol Depend 2010; 110 228–33.
| Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs.Crossref | GoogleScholarGoogle Scholar | 20430537PubMed |
[21] Chalmers J, Ritter A, Heffernan M, McDonnell G. Modelling pharmacotherapy maintenance in Australia: exploring affordability, availability, accessibility and quality using system dynamics. ANCD Research Paper #19. Canberra: Australian National Council on Drugs; 2009.
[22] Dray A, Mazerolle L, Perez P, Ritter A. Drug law enforcement in an agent-based model: simulating the disruption to street-level drug markets. In: Liu L, Eck J, editors. Artificial crime analysis systems: using computer simulations and geographic information systems. Hershey, PA: IGI Global; 2008. pp. 352–71.
[23] Dray A, Mazerolle L, Perez P, Ritter A. Policing Australia's ‘heroin drought': using an agent-based model to simulate alternative outcomes. J Exp Criminol 2008; 4 267–87.
| Policing Australia's ‘heroin drought': using an agent-based model to simulate alternative outcomes.Crossref | GoogleScholarGoogle Scholar |
[24] Perez P, Dray A, Ritter A, Dietze P, Moore T, Mazerolle L. SimDrug: exploring the complexity of illicit drug markets. In: Perez P, Batten D, editors. Complex science for a complex world – Exploring human ecosystems with agents. Canberra: ANU E press; 2006. pp. 193–224.
[25] Weiss CH, Murphy-Graham E, Birkeland S. An alternate route to policy influence: how evaluations affect D.A.R.E. Am J Eval 2005; 26 12–30.
| An alternate route to policy influence: how evaluations affect D.A.R.E.Crossref | GoogleScholarGoogle Scholar |
[26] Kingdon T. Agendas, alternatives, and public policy. 2nd ed. New York: Longman; 2003.
[27] Sabatier PA, editor. Theories of policy processes. Colorado: Westview Press; 2007.
[28] Ritter A, Bammer G. Models of policy making and their relevance for drug research. Drug Alcohol Rev 2010; 29 352–7.
| Models of policy making and their relevance for drug research.Crossref | GoogleScholarGoogle Scholar | 20636649PubMed |
[29] Matthew-Simmons F, Love S, Ritter A. Monograph 17: A review of Australian public opinion surveys on illicit drugs. DPMP Monograph Series. Sydney: National Drug and Alcohol Research Centre; 2008.
[30] Weiss CH. The many meanings of research utilization. Public Adm Rev 1979; 39 426–31.
| The many meanings of research utilization.Crossref | GoogleScholarGoogle Scholar |
[31] Ritter A. How do drug policy makers access research evidence? Int J Drug Policy 2009; 20 70–5.
| How do drug policy makers access research evidence?Crossref | GoogleScholarGoogle Scholar | 18226519PubMed |
[32] Nathan SA, Develin E, Grove N, Zwi AB. An Australian childhood obesity summit: the role of data and evidence in ‘public’ policy making. Aust New Zealand Health Policy 2005; 2 17
| An Australian childhood obesity summit: the role of data and evidence in ‘public’ policy making.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2MvntFajuw%3D%3D&md5=c8c63a01ba977d650ee10fb34af9b488CAS | 16029512PubMed |
[33] Van Beek I. In the eye of the needle: diary of a medically supervised injecting centre. Crows Nest: Allen & Unwin; 2004.